News and Announcements
Power Club Project Kicking off with Full Funds and a Retail Licence Obtained
- Published December 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Power Club granted Retail Authorisation by the Australian Energy Regulator
- Very limited opportunity to invest remains.
- Small opportunity to acquire shares before the underwrite triggers on the remaining shares this Friday 8th December 2017.
The last hurdle to Power Club entering the National Energy Market as a retailer has fallen. The Australian Energy Regular has granted Power Club authorisation to begin retailing in the national energy market to residential customers, businesses and commercial & industrial. There is still a limited opportunity to invest in this exciting project with Power Club’s new method for consumers to purchase energy at previously unavailable direct wholesale prices (Patents applied for in Australia, New Zealand and USA), eliminating previously unavoidable risk overhead with the savings driving prices substantially below current retail offers, all within a member-owned club which increases product loyalty. Power Club is to be one of the significant change agents bringing cheaper energy to everyday consumers.
Remaining investment beyond the underwritten shares has gone. There is still a small opportunity to acquire shares before the underwrite triggers on the remaining shares this Friday 8thDecember 2017. To allow smaller investors to participate it has been agreed to allow a very limited number of investors with a minimum of $50K instead of the previous $100K. Investment funds not required until 30 days after share commitment.
About Power Club Investments Pty Ltd
New patentable way for consumers to purchase power and services at previously unavailable direct wholesale prices. Approach eliminates previously unavoidable risk overhead and savings drives prices substantially below current retail offers with club increasing loyalty. Excellent investor returns through membership and Intellectual Property, both outside conventional retailer approach. IPO, entry to international markets and additional products envisaged in medium term.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
